{"id":"W4402787403","doi":"10.2139/ssrn.4954552","title":"Adverse Events in the Placebo Arm of Solo2/Engot-Ov21 Maintenance Trial of Olaparib in Recurrent Ovarian Cancer","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Olaparib; Ovarian cancer; Placebo; Adverse effect; Medicine; Oncology; Internal medicine; Cancer; Alternative medicine; Biology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001257967,0.0006359696,0.002061618,0.0002129576,0.0002442083,0.0008475496,0.0003951615,0.0007337973,0.004928961],"category_scores_gemma":[0.001601455,0.0002593681,0.00151194,0.0002994042,0.0003806794,0.0005766675,0.0002634839,0.001865469,0.0004405305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004717069,"about_ca_system_score_gemma":0.0006838031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004965317,"about_ca_topic_score_gemma":0.001058217,"domain_scores_codex":[0.9995093,0.0002864684,0.00003482478,0.00006569973,0.00004075105,0.00006295792],"domain_scores_gemma":[0.9994511,0.0002065803,0.0001401886,0.00005184489,0.00002870244,0.0001215633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9070052,0.001278089,0.001839169,0.0009055564,0.002186867,0.0001110262,0.00005677809,0.000719067,0.004881392,0.0002416257,0.002198673,0.07857656],"study_design_scores_gemma":[0.8232753,0.1316843,0.03004948,0.0002118753,0.00374269,0.0003312936,0.00008147505,0.002422615,0.002240665,0.001189845,0.004710715,0.00005969284],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984823,0.00937185,0.0004506012,0.0006221274,0.0002943507,0.000299962,0.001192214,0.00009269941,0.002853232],"genre_scores_gemma":[0.993192,0.002314341,0.000331535,0.0003921263,0.0002302994,0.0002840801,0.0007672749,0.00002364362,0.002464698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004928961,"threshold_uncertainty_score":0.01648909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02435074763467985,"score_gpt":0.3375228940333385,"score_spread":0.3131721463986586,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}